PGM3 and immune system disorder: A genotype–phenotype correlation is predicted for PGM3 deficiency, as evidenced by the consistent association of the same mutations with comparable severity in unrelated patients, suggesting that different mutations allow for residual PGM3 expression and/or activity levels that influence clinical outcomes, ranging from moderate to severe immunodeficiency.